English हिन्दी
Connect with us

India News

NITI Aayog health index report: Kerala tops again, Uttar Pradesh worst

Published

on

NITI Aayog health index report: Kerala tops again, Uttar Pradesh worst

[vc_row][vc_column][vc_column_text]Kerala has once again emerged as the top ranking state in the second health index report of NITI Aayog, while the worst is Uttar Pradesh at the bottom, preceded by Rajasthan, Bihar and Odisha.

The Health Index consists of 24 indicators grouped in the domains of  Health Outcomes, Governance and Information, and Key Inputs/Processes. The States and Union Territories (UTs) have been ranked in three categories to ensure comparison among similar entities – Larger States, Smaller States, and UTs. The second round of the health index accounts for the period 2015-16 (base year) to 2017-18 (reference year).

The report has been prepared in collaboration with the Ministry of Health and Family Welfare with technical assistance from the World Bank. The States were sensitized about the Health Index including indicator definitions, data sources and process for data submission through a series of regional workshops and mentor support was provided to most States.

Data was submitted by States on the online portal hosted by NITI Aayog and data from sources in the public domain was pre-entered. This data was then validated by an IVA and was used as an input into automated generation of Index values and ranks on the portal

Last year, in February the first round of the health index was released, which measured the annual and incremental performances of States and UTs for the period 2014-15(base year) to 2015-16 (reference year).

Here are some excerpts from the report:

In the base year (2014-15), the composite Health Index ranged from 28.14 in Uttar Pradesh to 80 in Kerala. On an average, modest improvement was observed between the base and reference year, with the difference between the worst and best performing States narrowing.

In the reference year 2015-16, Uttar Pradesh at 33.69 remained the poorest performing State,  and Kerala remained the best performing State despite a slight decline in the Health Index to 76.55.

The top five performing States in the reference year based on the composite Index score are  Kerala  (76.55), Punjab (65.21), Tamil Nadu (63.38), Gujarat (61.99), and Himachal Pradesh (61.20).

On the other end of the spectrum, Uttar Pradesh (33.69) scored the lowest and ranks at the bottom preceded by  Rajasthan  (36.79),  Bihar  (38.46),  Odisha  (39.43),  and  Madhya  Pradesh  (40.09).

Among the 21 Larger States, only five States improved their position from base to reference year. These States are Punjab,  Andhra  Pradesh,  Jammu  &  Kashmir, Chhattisgarh and Jharkhand.

The most significant progress was observed in Jharkhand and Jammu & Kashmir. Both States moved up by four positions in the ranking.

Punjab improved its performance in the ranking by three positions. Andhra Pradesh and Chhattisgarh have shown modest improvement – both up by one position.

Despite increases in the composite Health Index scores, the rankings of  Maharashtra, Madhya Pradesh, Bihar, Rajasthan, and Uttar Pradesh did not change between base and reference years.

Kerala continued to be at the top position and the remaining States fell in ranking by 1-2 positions.

There is a large gap in overall performance between the best and the least performing States and UTs; besides, all States and UTs have substantial scope for improvement:

In the reference year (2015-16) among Larger States, the Index score for overall performance ranged widely between 33.69 in Uttar Pradesh to 76.55  in  Kerala.  Similarly,  among  Smaller  States,  the  Index  score  for  overall  performance  varied  between  37.38  in  Nagaland  to  73.70  in  Mizoram,  and  among  UTs  this  varied  between 34.64 in Dadra & Nagar Haveli to 65.79 in Lakshadweep.

Among Larger States, the variation between the best and least performing States and UTs was the widest around 43 points as compared with 36 points in Smaller States and 31 points in UTs. However, based on the highest observed overall Index scores in each category of  States and UTs, clearly there is room for improvement in all States and UTs .

The States and UTs rank differently on overall performance and annual incremental   performance: States and UTs that start at lower levels of the Health Index (lower levels of  development of  their health systems) are generally at an advantage in notching up incremental progress over States with high Health Index score due to diminishing marginal returns in outcomes for similar effort levels. It is a challenge for States at high levels of the Index score even to maintain their performance levels. For  example, Kerala ranks on top in terms of overall  performance  and  at  the  bottom  in  terms  of   incremental progress mainly as it had already achieved a low level of  Neonatal Mortality Rate (NMR) and  Under-five  Mortality  Rate  (U5MR)  and  replacement  level  fertility,  leaving  limited  space  for  any  further improvements.

The incremental measurement shows that about one-third of the States have registered a decline in  their  Health  Indices  in  the  reference  year  as  compared  to  the  base  year:  This  is  a  matter  of   concern and should nudge the States into reviewing and revitalizing their programmatic efforts. Among the Larger States, six States, namely Uttarakhand, Himachal Pradesh, Karnataka, Gujarat, Haryana and Kerala have shown a decline in performance from base year to reference year, despite some of them being  among  the  top  ten  in  overall  performance.  Among the smaller states, Sikkim, Arunachal  Pradesh, Tripura and Nagaland have shown a decline; and among the UTs, Chandigarh and Daman & Diu have shown a decline.

The Health Index will  be  calculated  and  disseminated  annually,  with  a  focus  on  measuring  and  highlighting  annual  incremental improvement in the States and UTs, the NITI Aayog said in the report. The composite Health Index and ranking of  States and   UTs   will   assist   in   monitoring   the   States’   performance,   also   serving   as   an   input   for   performance-based incentives, leading ultimately to improvements in the state of  health in each State.

You might also be interested in:

[/vc_column_text][/vc_column][/vc_row]

India News

Sharad Pawar admitted to Mumbai hospital hours after Pune discharge

NCP (SP) chief Sharad Pawar was admitted to Mumbai’s Breach Candy Hospital hours after being discharged from Pune’s Ruby Hall Clinic, where he had been undergoing medical observation following complaints of cough and chest pain.

Published

on

Sharad Pawar

Nationalist Congress Party (Sharadchandra Pawar) chief Sharad Pawar was admitted to Mumbai’s Breach Candy Hospital on Wednesday, just hours after being discharged from Pune’s Ruby Hall Clinic. His daughter and Baramati MP Supriya Sule confirmed the development in a social media post, saying that the veteran politician was being admitted for further medical tests.

The 85-year-old leader had been discharged from Ruby Hall Clinic earlier on Wednesday after being admitted on November 2 following complaints of cough and pleuritic chest pain.

Confirming his admission to the Mumbai hospital, Supriya Sule said, “We are admitting Baba to Breach Candy Hospital for further tests. Thank you all for your concern and good wishes.”

Pawar’s latest hospitalisation came after he had undergone medical tests and observation during his stay at the Pune facility. Sule had earlier said that his health parameters were stable.

Why was Sharad Pawar admitted to hospital?

Sharad Pawar was initially admitted to Pune’s Ruby Hall Clinic on November 2 after experiencing complaints of cough and pleuritic pain, a form of chest pain that generally becomes worse while breathing, coughing or sneezing.

Dr Purvez K Grant, chief cardiologist, chairman and managing trustee of Ruby Hall Clinic, had said that Pawar was admitted for a general health check-up and medical observation following complaints of pleuritic pain.

During his hospital stay, Supriya Sule had informed that Pawar was undergoing medical tests and that his health parameters remained stable.

He was subsequently discharged from the Pune hospital on Wednesday. However, hours later, his family decided to admit him to Mumbai’s Breach Candy Hospital for further medical examinations.

PM Modi calls Sharad Pawar, advises complete rest

Prime Minister Narendra Modi also spoke to Sharad Pawar over the phone on Wednesday morning to enquire about his health.

According to Pawar’s aide Vitthal Maniyar, the Prime Minister spoke to the NCP (SP) chief and advised him to take complete rest.

Maniyar said Modi told Pawar that his daughter Supriya Sule and others were ready to take care of the country, and that the veteran politician should focus on his health.

Pawar thanked the Prime Minister for enquiring about his well-being, the aide said.

Maniyar also said that Pawar told Modi that he was resting and had no worries about the country, as others were there to take care of things.

The latest hospital admission was confirmed by Supriya Sule, who said her father was being taken to Breach Candy Hospital for further tests.

Continue Reading

Entertainment

Ramayana Day 1 Box Office: Ranbir Kapoor film eyes Rs. 100 crore-plus opening

Ramayana is expected to make a strong start at the Indian box office, with trade experts projecting a Day 1 opening of around Rs. 100 crore to Rs. 125 crore. The film’s China prospects remain uncertain.

Published

on

Ramayana Teaser

Nitesh Tiwari’s Ramayana is heading for a potentially massive opening at the Indian box office, with trade experts predicting that the film could collect more than Rs. 100 crore on its first day.

The film, starring Ranbir Kapoor, Yash and Sai Pallavi, is scheduled for theatrical release on November 5. Produced by Namit Malhotra, the mythological epic has generated significant expectations because of its cast, scale, music and visual effects.

Trade analyst Ramesh Bala has given the most optimistic domestic opening estimate, expecting around Rs. 125 crore gross in India on Day 1. He believes the Hindi version and the film’s premium-format availability could help drive its opening, particularly across the Hindi-speaking markets.

Exhibitor and trade analyst Akshaye Rathi has offered a slightly more conservative estimate, putting the film’s nationwide opening at around Rs. 100 crore or more across languages. He noted that the pre-Diwali release period could influence the opening numbers because audiences are occupied with Diwali preparations and shopping.

Veteran trade analyst Komal Nahta also expects the film to reach the Rs. 100-crore range across languages. His estimate is around Rs. 60 crore for the Hindi version, with the total across all languages potentially reaching Rs. 100 crore or more.

Ramayana vs Dhurandhar 2

One of the key box-office questions is whether Ramayana can surpass the opening-day performance of Dhurandhar 2.

Trade experts are cautious about making that comparison. Bala expects a strong opening but pointed out that Dhurandhar 2 benefited from being a sequel and having substantial pre-release hype.

Nahta believes Ramayana is unlikely to surpass Dhurandhar 2 on Day 1, partly because of the timing of its release. Rathi also expects a strong start but highlighted the pre-Diwali period as a factor that could affect the film’s initial numbers.

These are trade projections, rather than confirmed box-office figures. The actual Day 1 collection will depend on occupancy, spot bookings and audience response after the film’s release.

Why Ramayana has strong box-office potential

The film has several factors working in its favour. Its cast includes Ranbir Kapoor as Ram, Sai Pallavi as Sita and Yash as Ravana, while Nitesh Tiwari is directing the project.

The film also features music by AR Rahman and visual effects from DNEG, giving it a large-scale cinematic presentation. Trade experts believe the combination of mythology, star power and spectacle could attract audiences across different sections of the country.

The familiarity of the Ramayana story is another major factor. Experts believe its cultural and emotional connection with Indian audiences gives the film an advantage that many other releases do not have.

What could happen in China?

China is one of the biggest uncertainties surrounding Ramayana’s overseas prospects.

Nitesh Tiwari’s previous film Dangal had a major run in China, but trade experts have differing views on whether that success can be repeated with Ramayana.

Ramesh Bala has taken a cautious position. He pointed out that Dangal’s success was influenced by several factors and that Ramayana’s mythological subject may not have the same familiarity among Chinese audiences.

Akshaye Rathi, however, sees considerable international potential. He believes that audiences outside India could approach the Ramayana as a fresh story and that effective international marketing could help the film connect with viewers in markets such as China.

Komal Nahta is also optimistic about China and believes the emotional journey of Sita could appeal to Chinese audiences.

The film’s potential in China therefore remains an expectation rather than a confirmed outcome. Its eventual performance will depend on the scale of its release, marketing and audience reception.

Can Ramayana recover its reported budget?

The film has been widely associated with a reported budget of around Rs. 4,000 crore, although trade experts caution that this figure could relate to the two-part project rather than the first instalment alone.

Ramesh Bala suggested that the reported Rs. 4,000 crore figure could cover both parts and said the exact allocation for the first film remains unclear. Komal Nahta estimated the cost of the first part at around Rs. 1,200 crore.

The experts also pointed to non-theatrical revenue, including OTT and satellite rights, as important factors in determining whether the project can recover its investment.

Can Ramayana become India’s biggest film?

The possibility of Ramayana challenging major box-office records is also being discussed ahead of its release.

Bala said the film has the ingredients to compete at the highest level, while Rathi believes it has the potential to become the highest-grossing Indian film worldwide. Nahta, however, has avoided making a definitive prediction before audiences see the film.

The experts also differed on the film’s eventual worldwide theatrical earnings. Bala suggested that it could potentially reach Rs. 1,000-1,500 crore, while Nahta gave an even broader possible range. Rathi did not put a specific figure on it but said the film could potentially reach the top tier of Indian cinema’s global box-office performers.

Ticket prices could affect the opening

Another factor attracting attention is the premium pricing for formats such as IMAX.

Ramesh Bala expects the makers to benefit from higher ticket prices during the initial period but believes prices could come down after the opening week.

Komal Nahta defended the strategy, arguing that the pricing could help a film that has involved such a large reported investment. Audiences who do not want to pay premium prices could instead opt for regular screenings.

Ramayana’s box-office verdict will depend on audience response

While the pre-release projections point towards a major opening, the longer-term performance of Ramayana will ultimately depend on audience reception and word of mouth.

The trade experts broadly agree that the film has the scale, cast and story required for a major theatrical run. However, its actual performance in India, China and other international markets can only be established after its release.

For now, the projections indicate that Ramayana could cross the Rs. 100-crore mark in India on its opening day, while its potential to become one of the biggest Indian films globally remains dependent on how audiences respond to the film.

Continue Reading

India News

Four militants killed as rival Naga groups clash in Manipur village

Four militants were killed in a gunfight between suspected rival Naga groups at Taodaijang village in Manipur’s Noney district on Wednesday.

Published

on

Manipur violence

At least four militants were killed in a gunfight between suspected rival Naga militant groups in Manipur’s Noney district on Wednesday, November 4.

The exchange of fire took place at Taodaijang village in the Khoupum area of the Naga-majority district. According to officials, the cadres involved were suspected to belong to rival Naga militant outfits, including the Zeliangrong United Front-Jenchui (ZUF-J) and the Zeliangrong United Front-Kamson (ZUF-K).

Initial reports indicated that the gunfight continued for several hours, leaving three cadres of ZUF-J and one cadre of ZUF-K dead.

The bodies of the deceased militants were subsequently recovered by local residents.

Residents appeal to armed groups to stop firing

Following the gunfight, local residents, including women, reached the spot in an attempt to prevent further violence between the rival groups.

They also used a public address system to appeal to the armed cadres to stop firing and prevent the situation from escalating further.

Further details about the circumstances surrounding the clash were awaited.

Manipur government reviews security situation

In a separate development, Manipur Chief Minister Yumnam Khemchand Singh directed senior security officials to identify active armed groups suspected of involvement in recent incidents of violence in the state.

The directive excluded groups engaged in peace talks with the state government.

The Chief Minister issued the instructions during a review meeting on the state’s law and order situation on Tuesday night.

He also asked security agencies, including the Army and central paramilitary forces, to submit a detailed report on the involvement of the suspected groups.

The Chief Minister said the state Cabinet could consider declaring such groups unlawful if their involvement in violence against innocent civilians was established.

He also emphasised that necessary action would be initiated against groups continuing to perpetrate violence against civilians.

Continue Reading

Trending

© Copyright 2022 APNLIVE.com